Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing
© 2024. The Author(s)..
PURPOSE: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a relatively rare subtype of DLBCL. Herein, we report a case of a patient with EBV-positive iris DLBCL after undergoing penetrating keratoplasty and discuss its possible pathogenesis.
METHODS: A 72-year-old male patient presented to our hospital with progressive blurring of vision in the left eye for the past 4 months. Small white nodular lesions were observed on the iris and retinal surface of the left eye, with a white cloud-like opacity in the vitreous cavity.
RESULTS: The patient was eventually diagnosed with EBV-positive iris DLBCL after undergoing pathological and metagenomic tests. After injecting methotrexate in the left vitreous cavity and administering systemic and local antiviral treatments, the ocular lesions disappeared.
CONCLUSION: EBV infection, drug immunosuppression, and aging-related immune deterioration may play significant roles in the pathogenesis of EBV-positive iris DLBCL.
SYNOPSIS: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a new subtype of DLBCL, which rarely occurs. Herein, we report a case of a patient with EBV-positive iris DLBCL after undergoing penetrating keratoplasty and discuss its possible pathogenesis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
BMC ophthalmology - 24(2024), 1 vom: 04. März, Seite 99 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Xiao-Na [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 06.03.2024 Date Revised 07.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12886-024-03334-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369287304 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369287304 | ||
003 | DE-627 | ||
005 | 20240307232536.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240305s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12886-024-03334-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1319.xml |
035 | |a (DE-627)NLM369287304 | ||
035 | |a (NLM)38438866 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Xiao-Na |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.03.2024 | ||
500 | |a Date Revised 07.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a PURPOSE: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a relatively rare subtype of DLBCL. Herein, we report a case of a patient with EBV-positive iris DLBCL after undergoing penetrating keratoplasty and discuss its possible pathogenesis | ||
520 | |a METHODS: A 72-year-old male patient presented to our hospital with progressive blurring of vision in the left eye for the past 4 months. Small white nodular lesions were observed on the iris and retinal surface of the left eye, with a white cloud-like opacity in the vitreous cavity | ||
520 | |a RESULTS: The patient was eventually diagnosed with EBV-positive iris DLBCL after undergoing pathological and metagenomic tests. After injecting methotrexate in the left vitreous cavity and administering systemic and local antiviral treatments, the ocular lesions disappeared | ||
520 | |a CONCLUSION: EBV infection, drug immunosuppression, and aging-related immune deterioration may play significant roles in the pathogenesis of EBV-positive iris DLBCL | ||
520 | |a SYNOPSIS: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a new subtype of DLBCL, which rarely occurs. Herein, we report a case of a patient with EBV-positive iris DLBCL after undergoing penetrating keratoplasty and discuss its possible pathogenesis | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Epstein-Barr virus | |
650 | 4 | |a Lymphoma | |
650 | 4 | |a mNGS | |
700 | 1 | |a Hong, Jing |e verfasserin |4 aut | |
700 | 1 | |a Xu, Yong-Gen |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Pei |e verfasserin |4 aut | |
700 | 1 | |a Li, Ying-Yu |e verfasserin |4 aut | |
700 | 1 | |a Dou, Hong-Liang |e verfasserin |4 aut | |
700 | 1 | |a Li, Hai-Ping |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC ophthalmology |d 2001 |g 24(2024), 1 vom: 04. März, Seite 99 |w (DE-627)NLM11233282X |x 1471-2415 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g day:04 |g month:03 |g pages:99 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12886-024-03334-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 1 |b 04 |c 03 |h 99 |